Seminars in Oncology
Volume 31, Issue 4 , Pages 444-449 , August 2004

Are cancers of the esophagus, gastroesophageal junction, and cardia one disease, two, or several?

  • Valerie W. Rusch

      Affiliations

    • Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    • Corresponding Author Information Address reprint requests to Valerie W. Rusch, MD, Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Room C-868, New York, NY 10021 USA

References 

  1. Devesa SS, Fraumeni JF. The rising incidence of gastric cardia cancer. J Natl Cancer Inst. 1999;91:747–749
  2. Sharma P. Cancer of the esophagogastric junction (Epidemiology and pathogenesis). J Gastrointest Surg. 2003;6:516–517
  3. Siewert JR, Feith M, Werner M, et al.  Adenocarcinoma of the esophagogastric junction. Results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg. 2000;232:353–361
  4. Wu AH, Wan P, Bernstein L. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States). Cancer Causes Control. 2001;12:721–732
  5. Eksteen JA, Latchford A, Thomas SJ, et al.  Commentary (Regional variations in oesophgeal and gastric cardia cancers—Implications and practice). Int J Epidemiol. 2001;30:1425–1427
  6. Corley DA, Buffler PA. Oesophageal and gastric cardia adenocarcinomas (Analysis of regional variation using the Cancer Incidence in Five Continents database). Int J Epidemiol. 2001;30:1415–1425
  7. Engel LS, Chow W-H, Vaughan TL, et al.  Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95:1404–1413
  8. Wu AH, Tseng C-C, Bernstein L. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma. Cancer. 2003;98:940–948
  9. Gao C-M, Takezaki T, Wu J-Z, et al.  Glutathione-S-transferases M1 (GSTM1) and GSTT1 genotype, smoking, consumption of alcohol and tea and risk of esophageal and stomach cancers (A case-control study of a high-incidence area of Jiangsu Province, China). Cancer Lett. 2002;188:95–102
  10. Beuzen F, Dubois S, Fléjou J-F. Chromosomal numerical aberrations are frequent in oesophageal and gastric adenocarcinomas (A study using in-situ hybridization). Histopathology. 2000;37:241–249
  11. El-Rifai W, Frierson HF, Hoskaluk CA, et al.  Genetic differences between adenocarcinomas arising in Barrett’s esophagus and gastric mucosa. Gastroenterology. 2001;121:592–598
  12. Tanièe P, Martel-Planche G, Maurici D, et al.  Molecular and clinical differences between adenocarcinomas of the esophagus and of the gastric cardia. Am J Pathol. 2001;158:33–40
  13. Ormsby AH, Goldblum JR, Rice TW, et al.  The utility of cytokeratin subsets in distinguishing Barrett’s-related oesophageal adenocarcinoma from gastric adenocarcinoma. Histopathology. 2001;38:307–311
  14. Akiyama H, Tsurumaru M, Kawamura T, et al.  Principles of surgical treatment for carcinoma of the esophagus (analysis of lymph node involvement). Ann Surg. 1981;194:438–446
  15. Dresner SM, Lamb PJ, Bennett MK, et al.  The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery. 2001;129:103–109
  16. Conlon KC. Staging laparoscopy for gastric cancer. Ann Ital Chir. 2001;72:33–37
  17. Krasna MJ, Jiao X, Mao YS, et al.  Thoracoscopy/laparoscopy in the staging of esophageal cancer. Maryland experience. Surg Laparosc Endosc. 2002;12:213–218
  18. Krasna MJ, Reed CE, Nedzwiecki D, et al.  CALGB 9380 (A prospective trial of the feasibility of thoracoscopy/laparoscopy in staging esophageal cancer). Ann Thorac Surg. 2001;71:1073–1079
  19. American Joint Committee on Cancer . AJCC Cancer Staging Handbook. (ed 6). New York, NY: Springer-Verlag; 2002;

PII: S0093-7754(04)00244-1

doi: 10.1053/j.seminoncol.2004.04.023

Seminars in Oncology
Volume 31, Issue 4 , Pages 444-449 , August 2004

Article Tools

* Image Usage & Resolution